Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can blood pressure meds after delivery keep new moms out of the hospital?

NCT ID NCT04298034

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 37 times

Summary

This study tests whether giving blood pressure medication to women after childbirth can prevent hospital readmissions and reduce severe high blood pressure. About 300 women with preeclampsia will either receive standard care or start blood pressure drugs like labetalol or nifedipine. The goal is to see if treatment lowers the need for extra medical visits and improves recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Medical College of Wisconsin-Froedtert Hospital

    Milwaukee, Wisconsin, 53226, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Labetalol and Nifedipine (blood pressure medications)

What this could lead to

If successful, this could show that treating high blood pressure after childbirth reduces hospital readmissions and the need for extra doctor visits for women with preeclampsia.

What could go wrong

This is a Phase 3 trial, but it only compares treatment to no treatment, not to a placebo. Results may not apply to all women, and the medications can have side effects like dizziness or fatigue.

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.